-
Roth Capital Starts Shopify, XO Group, Mitek At Buy
Friday, April 15, 2016 - 8:58am | 328Read More...Roth Capital's Darren Aftahi initiated coverage on three Internet and media stocks Thursday afternoon: Shopify Inc (NYSE: SHOP), XO Group Inc (NYSE: XOXO) and Mitek Systems, Inc. (NASDAQ: MITK), each with Buy ratings. Shopify: $35 Price Target Aftahi called Shopify "a pure-play on agnostically...
-
Roth Still Selling Etsy Despite Pattern Launch
Wednesday, April 6, 2016 - 3:12pm | 311Read More...Shares of Etsy Inc (NASDAQ: ETSY) were trading up roughly 1.8 percent on Wednesday afternoon, even though Roth Capital reiterated a Sell rating and $6.00 price target on the stock. Analyst Darren Aftahi explained that, while the addition of Pattern to the company’s seller services portfolio...
-
Analysts On First Solar's Short-Term Outlook: 'Meh'
Wednesday, April 6, 2016 - 1:34pm | 744Read More...First Solar, Inc. (NASDAQ: FSLR)'s Analyst Day fell short of investor expectations, as investors were expecting the company to provide 2017 guidance as it has in the past. While 2017 guidance was not given, First Solar did provide a long-term vision that pacified Wall Street, who still remains...
-
Are More Solar Asset-Backed Securities Coming?
Monday, March 28, 2016 - 11:18am | 393Read More...Back in September of 2015, AES Distributed Energy announced a new solar asset-backed securities (ABS) offering. Together with four other similar offerings by SolarCity Corp (NASDAQ: SCTY) and Sunrun Inc (NASDAQ: RUN), the total amount of solar ABS offerings at the time had reached $560.5 million...
-
Here's Why Redbox Digital Won't Save Outerwall
Monday, March 28, 2016 - 9:30am | 486Read More...Shares of Redbox-owner Outerwall Inc (NASDAQ: OUTR) gained last week after Variety reported that Redbox plans to launch a new video streaming service called Redbox Digital. However, Darren Aftahi of Roth Capital sees the strategy as "frankly too little, too late," given the commoditization of the...
-
Roth's Piros: Galectin Therapeutics Shares Can Quadruple In Next 12 Months
Wednesday, March 9, 2016 - 4:00pm | 449Read More...Shares of Galectin Therapeutics Inc (NASDAQ: GALT) could reach $6 in the next 12 months, according to Roth Capital's Elemer Piros who initiated the stock with a Buy rating. Galectin is developing a drug that could prevent and reverse fibrosis in nonalcoholic steatohepatitis (NASH) patients...
-
EXCLUSIVE: Digital Ally CEO Talks TASER Lawsuit, Upcoming Presentation
Wednesday, March 9, 2016 - 2:37pm | 443Read More...Digital Ally, Inc. (NASDAQ: DGLY) stock might be in for some volatility on March 15. At the Roth Capital Conference on March 15, Digital Ally plans to discuss the ongoing TASER International, Inc. (NASDAQ: TASR) lawsuit, Digital Ally CEO Stan Ross told Benzinga. Stating he believes Digital...
-
Digital Ally Falls 5% After Big Earnings Miss
Monday, March 7, 2016 - 4:30pm | 152Read More...Early Monday afternoon, Digital Ally, Inc. (NASDAQ: DGLY) reported quarterly results. The release may have been come sooner than planned.Falls Q4's EPS came in at $(0.40) versus an estimated $(0.18). Sales came in at $5.051 million versus the estimated $5.70 million. Following this...
-
Tencent Ups Glu Mobile Stake Even More, Now Has 21.5% Of Company
Friday, February 26, 2016 - 3:49pm | 317Read More...China's Tencent has raised its stake in mobile game maker Glu Mobile Inc. (NASDAQ: GLUU) to 21.5 percent, according to regulatory filings on SEC. Tencent, an Internet service portal in China, bought 4 million more shares of Glu Mobile – which is bringing Tencent's top-grossing Asian-market...
-
SodaStream Ready To Report Holiday Numbers
Tuesday, February 16, 2016 - 2:34pm | 431Read More...According to a recent report by Roth Capital Partners' Anton Brenner, Sodastream International Ltd (NASDAQ: SODA)'s Q4 results due Thursday are likely to show a revenue decline and a $0.17 difference to the downside in EPS compared to last year. Brenner provided the following...
-
Feuerstein Not Excited About JPMorgan Biotech Conference
Monday, January 11, 2016 - 9:22am | 299Read More...JPMorgan's Annual Healthcare Conference is one of the largest gathering of healthcare companies, executives, investors, and other stakeholders and kicks off on Monday. Chris Lewis of Roth Capital Partners commented in a note on January 5 that he is expecting "a number of...
-
Flex Pharma Could Still Double From Here, Roth Analyst Says
Wednesday, January 6, 2016 - 2:02pm | 136Read More...Shares of Flex Pharma Inc (NASDAQ: FLKS) have lost 19 percent of value over the past year, but Joseph Pantginis of Roth Capital Partners is estimating the stock could double in value from its current valuation. Pantginis noted that following the completion of enrollment in the NLC study suing the...
-
Roth Capital Defends Flamel Tech Selloff, Says It's 'Overdone' And Worth $21 Per Share
Thursday, December 31, 2015 - 2:58pm | 434Read More...In a report issued Thursday, Roth Capital analyst Scott R. Henry shared a look into Flamel Technologies S.A. (ADR) (NASDAQ: FLML), and the increasing competition its Bloxiverz faces -– and will continue to face. After taking this into account, the expert decided to reiterate a Buy...
-
Prima BioMed Shares Rally Following New Buy Rating, $6 Target From Roth Capital
Thursday, December 31, 2015 - 9:26am | 268Read More...Prima BioMed Ltd (ADR) (NASDAQ: PBMD) shares jumped 13 percent in premarket trading on December 31. Roth Capital’s Joseph Pantginis initiated coverage of the company with a Buy rating and a price target of $6. Initial clinical efficacy of LAG-3 has been promising, putting the...
-
Roth Capital Shines Positive On Solar: Upgrades JA Solar, ReneSola, Enphase
Wednesday, December 16, 2015 - 3:03pm | 387Read More...Solar energy companies' shares are rallying Wednesday following the agreement by congressional leaders to extend a significant tax credit for the industry. Roth Capital gave Buy ratings across the sector for nearly all solar stocks. A Budget Deal For The Solar Industry Congressional Republican...
